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Abstract Lassa virus glycoprotein is synthesized as precursor
GP-C into the lumen of the endoplasmic reticulum and cleaved
posttranslationally into the N-terminal subunit GP-1 and the
C-terminal subunit GP-2 by subtilase SKI-1/S1P. The N-termi-
nal portion of the primary translation product preGP-C con-
tains a signal peptide of unknown length. In order to demon-
strate the signal peptide cleavage site, puri¢ed viral GP-1
isolated from Lassa virus particles was N-terminally sequenced
as TSLYKGV, identical to amino acids 59^65 of GP-C. Muta-
tional analysis of the amino acid residues £anking the putative
cleavage site led to non-cleavable preGP-C indicating that no
other signal peptide cleavage site exists. Interestingly, GP-C
mutants with a non-cleavable signal peptide were not further
processed by SKI-1/S1P. This observation suggests that the
signal peptide cleavage is necessary for GP-C maturation and
hence for Lassa virus replication.
3 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Signal peptides play a major role in sorting and membrane
integration of secretory and membrane proteins [1]. Signal
peptides are usually composed of three domains: an N-termi-
nal highly variable domain with a usually net positive charge,
a hydrophobic membrane-spanning domain comprising 6^15
amino acids, and normally a short C-terminal polar domain
with small uncharged residues at the 31 and 33 position
recognized by signal peptidase [2]. The total length of most
signal sequences di¡ers between 15 and 30 residues. Some
signal sequences, however, show great variation in size and
complexity. Over recent years, it has become clear that ex-
tended signal peptides may perform various additional func-
tions besides the well known translocation of secretory and
membrane-bound proteins across the membrane of the endo-
plasmic reticulum (ER). More and more examples of signal
peptides, also of viral proteins, with additional biological sig-
ni¢cance have been investigated, for instance the signal pep-
tide of the Foamy virus glycoprotein (GP) which is essential
for particle egress of virions [3], the complete HIV gp120
signal peptide which retards the exocytosis of gp120 from
the ER, and a proteolytic fragment of HIV gp120 signal pep-
tide which binds to calmodulin. The functions of the latter
two processes are not yet understood [4,5]. Another example
is an immunodominant T-cell epitope within the signal pep-
tide of the lymphocytic choriomeningitis virus (LCMV) GP
that is conserved among all Arenaviridae [6,7].
Lassa virus, like LCMV, belongs to the large family of
Arenaviridae comprising also other important human patho-
gens, like the viruses causing Argentine and Bolivian hemor-
rhagic fever. Lassa virus causes annually up to 100 000 cases
of clinically apparent Lassa fever in West Africa, with 10^20%
of the patients developing hemorrhagic manifestations and a
total mortality of about 15% [8,9]. This disease is increasingly
exported from endemic regions to other parts of the world
[10].
The GPs of Lassa virus and LCMV have recently been
shown to be posttranslationally processed by subtilase subti-
lisin kexin isoenzyme-1/site 1 protease (SKI-1/S1P) at a non-
basic cleavage site which is unusual for fusogenic GPs of
enveloped viruses [11^13]. However, the preceding cotransla-
tional signal peptide cleavage of the Lassa virus GP has not
been investigated so far. Neither the exact cleavage site(s), nor
the real length of the signal peptide, nor the putative biolog-
ical function(s) are known.
By determining the N-terminus of the GP subunit GP-1 and
by mutating the potential cleavage site we could demonstrate
that the signal peptidase cleaves only between threonine resi-
dues 58 and 59 of preGP-C. Surprisingly, preGP-C mutants
containing non-cleavable signal peptide were not further pro-
teolytically processed into GP-1 and GP-2, suggesting that the
free signal peptide may have an additional function during
virus replication beyond passing preGP-C through the ER
membrane.
2. Materials and methods
2.1. Cell cultures and virus propagation
Vero cells were cultured in Dulbecco’s modi¢ed Eagle’s medium
(DMEM, Gibco) supplemented with 10% fetal calf serum, 100 U/ml
penicillin, and 0.1 mg/ml streptomycin. Experiments with Lassa virus
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(strain Josiah) were performed under biosafety level 4 biocontainment
conditions. Vero cells were infected with Lassa virus at a multiplicity
of infection of 1. Cells were collected on day 4 post infection and
infectious material was inactivated by boiling at 95‡C for 10 min in
presence of 1% sodium dodecyl sulfate (SDS) before viral protein was
subjected to SDS^polyacrylamide gel electrophoresis (SDS^PAGE).
2.2. Puri¢cation of viral GP-1 and N-terminal amino acid analysis
The puri¢cation steps for GP-2 have been described in detail before
[11]. Brie£y, Lassa virus obtained from supernatants of virus-infected
Vero cells and freed from cell debris by centrifugation (2000 rpm,
10 min) was pelleted through a 20% sucrose cushion by ultracentri-
fugation (20 000 rpm, 2 h, 5‡C, SW28 rotor, Beckman) and further
puri¢ed over a two-step Optiprep gradient (8%/30%) (Sigma). Viral
protein of the gradient fractions was treated with peptide-N-glycosi-
dase F (PNGase F), separated by gel electrophoresis (2.6), blotted
onto a polyvinylidene di£uoride (PVDF) membrane, and stained
with Coomassie brilliant blue. The stained, deglycosylated GP-1
band was excised and the N-terminus determined by Edman degra-
dation (WITA, Berlin-Teltow, Germany).
2.3. Mutation and vectorial expression of recombinant Lassa GP
The full-length GP and the signal peptide of Lassa virus (strain
Josiah) were expressed using the L-actin promoter-driven pCAGGS
vector [11,13]. Lassa Virus preGP-C mutants were generated by re-
combinant polymerase chain reaction using overlapping oligonucleo-
tides, which will be made available on request [14]. Sequences were
con¢rmed by DNA sequencing. Vero cells were transfected with wild
type and mutated recombinant DNA using Lipofectamine 2000 (Gib-
co/Invitrogen).
2.4. Antibodies
Oligopeptides comprising the amino acids 2^18 and 477^491 of
preGP-C were chemically synthesized and covalently linked to key-
hole limpet hemocyanin (KLH, Pierce) as a carrier protein by the bi-
functional agent N-[K-maleimidoacetoxy] succinimide ester. The oli-
gopeptide^KLH was used for repeated immunization of rabbits as
described before [11]. The obtained antisera (Rb-K-SP and Rb-K-
GP2) were tested by peptide standard ELISA [15] and used for im-
munoprecipitation (Rb-K-SP) or immunoblot (Rb-K-GP2) analyses.
2.5. Acrylamide gel electrophoresis using Tris and tricine bu¡ers,
immunoblotting, and glycosidase treatment
Proteins were separated by two di¡erent methods: (i) SDS^PAGE
as described by Laemmli [16] using 10% or 12% acrylamide gels, and
(ii) SDS^PAGE as described by Scha«gger and von Jagow [17] using
16.5% polyacrylamide gel and N-tris[hydroxymethyl]methylglycine
(tricine) bu¡er. Protein samples were dissolved in electrophoresis sam-
ple bu¡ers containing either 100 mM Tris^HCl (pH 6.8), 4% SDS,
10% 2-mercaptoethanol, 20% glycerol and 0.05% bromophenol blue
(four-fold) or 200 mM Tris^HCl (pH 6.8), 16% SDS, 8% 2-mercap-
toethanol, 48% glycerol and 0.04% Serva blue G (four-fold). Immu-
noblotting was performed as described before [12]. Where indicated,
samples were treated with PNGase F (New England Biolabs) at 37‡C
overnight.
2.6. Pulse-chase experiments, and immunoprecipitation
Plasmid-transfected Vero cells were starved 20 h post transfection
for 1 h with DMEM lacking methionine and cysteine, before cells
were labelled with [35S]methionine and [35S]cysteine for 30 min. The
radioactive medium was replaced by DMEM for a 4-h chase. The
labelled cells were lysed in radioimmunoprecipitation assay bu¡er
and sonicated (40 W, Branson soni¢er). Non-soluble material was
removed and supernatants of the cell lysates incubated overnight
with protein A-Sepharose-coupled antibodies. Precipitated immuno-
complexes were subsequently analyzed by SDS^PAGE followed by
autoradiography on BioMax ¢lms (Kodak).
3. Results and discussion
3.1. Identi¢cation of the N-terminus of Lassa virus GP-1
Several di¡erent signal peptide cleavage sites are possible
for Lassa virus preGP-C. To locate the signal peptide cleavage
site, we determined the N-terminus of the distal GP-1 subunit.
GP-1 was puri¢ed from Lassa virus particles. The viral GPs
were deglycosylated to obtain a sharp Coomassie blue-stain-
able band on the PVDF blot membrane and then subjected to
SDS^PAGE and subsequently blotted. The band representing
GP-1 was analyzed using Edman degradation. The ¢rst seven
degradation cycles unambiguously revealed the amino acid
sequence TSLYKGV (Fig. 1). This sequence is identical to
the amino acids comprising threonine 59 to valine 65 of
preGP-C, indicating that the signal peptide is cleaved after
position 58.
3.2. Identi¢cation of the Lassa virus GP signal peptide
In order to prove or disprove the possibility that the signal
peptide may be additionally cleaved elsewhere in the N-termi-
nal direction, single amino acid residues £anking threonine 58
were substituted by large positively charged arginine residues.
In general, signal peptide cleavage depends on small un-
charged amino acids at positions 31 and 33 of the cleavage
site and does not allow an arginine residue in these positions
[2]. Thus we individually mutated the four small uncharged
residues glycine 54, serine 56, threonine 58 and serine 60 of
preGP-C, which are located around the cleavage site and
could function as a recognition sequence for the signal pepti-
dase, into arginine residues (Fig. 1). Recombinant wild type
and mutated Lassa virus GP was then vectorially expressed in
Vero cells and labelled radioactively in a pulse-chase experi-
ment. The signal peptide, GP-C and preGP-C were detected
by immunoprecipitation and autoradiography using the rabbit
antisera Rb-K-SP and RB-K-GP2, respectively (Fig. 2). The
released signal peptide of wild type and mutants G54R, S60R
and as controls the recombinant signal peptide (aa 1^58) as
well as material from Lassa-infected Vero cells were identi¢ed
as bands with an apparent molecular mass of about 3.6 kDa
on the 16.5% acrylamide gel (Fig. 2A). In contrast, released
signal peptide of the mutants S56R and T58R was not detect-
able (Fig. 2A, lanes 3 and 4). Moreover, when radioactively
labeled Lassa virus GP was precipitated with antibody Rb-K-
GP2, deglycosylated and separated by 12% acrylamide elec-
trophoresis, more slowly migrating bands appeared with mu-
tants S56R and T58R in comparison to wild type, G54R and
S60R. This suggests that the signal peptide was not or was
only imperfectly split o¡ from the primary gene product
preGP-C of these mutants leading to a single band (mutant
Fig. 1. Schematic overview of Lassa virus GP. The primary transla-
tion product preGP-C (aa 1^491), the signal peptide (SP) (aa 1^58),
the precursor GP-C (aa 59^491) and the subunits GP-1 (aa 59^259)
and GP-2 (260^491) containing the membrane anchor (stripes, aa
427^450) are shown. The antiserum binding sites, Rb-K-SP (aa 2^
18) and Rb-K-GP2 (aa 477^491), the signal peptidase (SPase) cleav-
age site between threonine residues 58 and 59 (arrow), the SKI-1/
S1P cleavage site C-terminal of leucine 259 (arrow), and putative N-
glycosylation sites (tree-like symbols) are indicated. The total signal
peptide sequence and C-terminally adjacent amino acid residues be-
longing to GP-1 are shown in one-letter code beneath. Single under-
lined amino acids are substituted in the signal peptide mutants.
Amino acids overlaid with a striped line were determined by Edman
degradation of GP-1.
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T58R) or a double band (mutant S56R) (Fig. 2B, lanes 3 and
4). The corresponding signal peptide band of the S56R mu-
tant is apparently too weak to appear in Fig. 2A. These data
demonstrate that Lassa virus GP possesses only one, 58 res-
idues long signal peptide which is cleaved between threonine
residues 58 and 59 with threonine 58 and serine 56 serving as
the recognition motif for the eukaryotic signal peptidase. The
sequenced N-terminus of LCMV GP-1 indicated that signal
peptide cleavage occurs at the homologous position of preGP-
C, although the amino acids at the cleavage site are not iden-
tical [6].
Using di¡erent durations of chase in pulse-chase experi-
ments we also found that complete cleavage of the signal pep-
tide can be detected already after a 10 min pulse with the wild
type and mutants G54R and S60R, while for mutants T58R
and S56R even after 15 h of chase no or only very little cleav-
age was detectable, indicating that cleavage of Lassa virus
preGP-C occurs only cotranslationally. Interestingly, the re-
leased signal peptide was still detected after 15 h of chase. In
analogy, the LCMV GP-C signal peptide is also very stable
and can still be detected after several hours (M. Froeschke,
M. Groettrup and B. Dobberstein, personal communication).
In addition, an in vitro-transcribed and translated signal pep-
tide migrates to the same position on acrylamide gels indicat-
ing that the released signal peptide is not processed further
(data not shown). Taken together we show that the released
full-length signal peptide is cotranslationally released and not
degraded immediately after cleavage from preGP-C like usual
signal peptides. We therefore suggest that the Lassa virus GP
signal peptide may have an additional function.
3.3. Signal peptide cleavage is essential for maturation cleavage
of GP-C
The highly extended length of the signal peptide with 58
residues leads to the question of the use of such an unusually
long signal peptide. In an attempt to reveal possible further
functions of the signal peptide apart from ER translocation,
we addressed the question whether the release of the signal
peptide is necessary for the maturation cleavage of GP-C by
SKI-1/S1P. For this purpose, we analyzed wild type GP-C
and the signal peptide cleavage site mutants with respect to
the maturation cleavage of GP-C into GP-1 and GP-2 by
SKI-1/S1P using the antiserum Rb-K-GP2 which recognizes
the non-cleaved GP and the membrane-anchored GP-2, but
not GP-1. GP-2 is not detectable in the signal peptide cleav-
age-defective mutants T58R and S56R, whereas the other
substitution mutants (mutants G54R and S60R) do not
a¡ect the maturation cleavage of GP-C into GP-1 and GP-2
(Fig. 3).
Since SKI-1/S1P resides in the ER, it is surprising to see
that preGP-C, which should also be present in the ER, is not
cleaved by SKI-1/S1P, whereas GP-C is cleaved by SKI-1/S1P
before it reaches the medial Golgi [12]. Thus, cleavage of the
signal peptide could be a prerequisite for the transport of the
GP precursor to a late ER or early Golgi compartment where
the maturation cleavage could occur. This explanation ap-
pears unlikely since preliminary data indicate that mutant
preGP-C is at least transported to the Golgi complex (data
not shown). Another explanation could be the masking of the
maturation cleavage site C-terminally of amino acid 259 by
the covalently bound signal peptide. It is also conceivable that
preGP-C is not folded correctly and thus is not exposing the
maturation cleavage site to SKI-1/S1P.
However, our data clearly show that the signal peptide
cleavage is a primary essential step before the secondary
step, the maturation cleavage of GP-C, can occur. Whether
the cleavage process of the signal peptide itself or the released
signal peptide, for instance as an intramolecular chaperone,
plays the crucial role for the secondary step, the cleavage of
GP-C by SKI-1/S1P, is currently under investigation. The
latter possibility is favored by the unusual length of the signal
peptide which comprises a wide range of predominantly hy-
drophobic amino acid residues indicating that this peptide
might be responsible for other functions.
Since activation cleavage of GP-C by SKI-1/S1P is a pre-
requisite for the generation of infectious virions, the speci¢c
inhibition of the Lassa virus signal peptide cleavage which is
essential for the maturation cleavage may also be discussed as
a potential therapeutic target. This possible therapeutic con-
cept and the unusual length of the signal peptide make the
study of its function and structure, as well as the elucidation
of its viral and cellular interaction partners, highly interesting.
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Fig. 2. Identi¢cation of the signal peptide cleavage site within Lassa
virus GP. Vero cells were transfected with pCAGGS-LaGPC vector
constructs containing wild type (WT), substitution mutants (G54R,
S56R, T58R, and S60R), the recombinant signal peptide (pCAGGS-
LaSP), or as a control with pCAGGS (M). The expressed proteins
were either pulse-chase-labelled with [35S]methionine/cysteine, immu-
noprecipitated (A) with the antiserum Rb-K-SP, and separated by
SDS^tricine/PAGE and analyzed by autoradiography or (B) with
Rb-K-GP2, treated with PNGase F and separated by SDS^PAGE
on 12% acrylamide gels, and analyzed by autoradiography (B). For
abbreviations see Fig. 1.
Fig. 3. Proteolytic processing of Lassa virus GP by SKI-1/S1P.
Vero cells were transfected with wild type (WT), mutants of the re-
combinant Lassa virus GP and mock-transfected (M). Virus GP
was separated on 10% acrylamide gels by SDS^PAGE and immuno-
blotted. Non-cleaved GP-C and its cleaved form GP-2 are detected
by immunostaining using the antiserum Rb-K-GP2.
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